Accuray (ARAY) Share-based Compensation Growth (1y) (2011 - 2026)
Accuray (ARAY) Share-based Compensation Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 9.69% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 3.57% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -4.08% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 12.16% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 12.94% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -30.44% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 26.61% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 59.09% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 31.63% |
| 10 | Accuray | 41,092.55 | -38.49 Mn | 25.29 Mn | -49.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49.76% |
| Dec 31, 2025 | -61.43% |
| Sep 30, 2025 | 6.93% |
| Mar 31, 2025 | 0.37% |
| Dec 31, 2024 | -1.30% |
| Sep 30, 2024 | -1.63% |
| Mar 31, 2024 | 75.43% |
| Dec 31, 2023 | -25.98% |
| Sep 30, 2023 | -17.97% |
| Mar 31, 2023 | -42.26% |
| Dec 31, 2022 | 16.04% |
| Sep 30, 2022 | 15.90% |
| Mar 31, 2022 | 8.48% |
| Dec 31, 2021 | 13.96% |
| Sep 30, 2021 | 12.12% |
| Mar 31, 2021 | 23.46% |
| Dec 31, 2020 | 10.00% |
| Sep 30, 2020 | 32.00% |
| Jun 30, 2020 | -18.96% |
| Mar 31, 2020 | -30.00% |